Digital program aims to curb diabetes risk in hispanic youth
NCT ID NCT06943001
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study adapts a diabetes prevention program for Hispanic adolescents aged 12-16 with obesity, delivering it via telehealth using a Fitbit, chatbot, and online lessons. The goal is to see if this approach is feasible and acceptable for reducing type 2 diabetes risk. Researchers will measure recruitment, retention, and satisfaction to inform a larger future study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fit24+ (digital program with Fitbit, chatbot, eLearning)
- What this could lead to
- If successful, this could provide an effective way to prevent type 2 diabetes in high-risk Hispanic teens, addressing barriers like transportation and scheduling.
- What could go wrong
- This is a small feasibility study with only 40 participants, so results may not apply broadly. The program's success depends on engagement and technology access.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine
RECRUITINGHouston, Texas, 77003, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test